DE3879395D1 - Fusionsprotein, enthaltend lymphotoxin. - Google Patents

Fusionsprotein, enthaltend lymphotoxin.

Info

Publication number
DE3879395D1
DE3879395D1 DE8888904653T DE3879395T DE3879395D1 DE 3879395 D1 DE3879395 D1 DE 3879395D1 DE 8888904653 T DE8888904653 T DE 8888904653T DE 3879395 T DE3879395 T DE 3879395T DE 3879395 D1 DE3879395 D1 DE 3879395D1
Authority
DE
Germany
Prior art keywords
protein
fusion protein
lymphotoxin
ppralt
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888904653T
Other languages
English (en)
Other versions
DE3879395T2 (de
Inventor
Tetsuzo Miki
Seishi Kato
Hiroshi Osada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nissan Chemical Corp
Sagami Chemical Research Institute
Tosoh Corp
Original Assignee
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nissan Chemical Corp
Sagami Chemical Research Institute
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Glass Co Ltd, Hodogaya Chemical Co Ltd, Nissan Chemical Corp, Sagami Chemical Research Institute, Tosoh Corp filed Critical Central Glass Co Ltd
Publication of DE3879395D1 publication Critical patent/DE3879395D1/de
Application granted granted Critical
Publication of DE3879395T2 publication Critical patent/DE3879395T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8888904653T 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin. Expired - Fee Related DE3879395T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13172687 1987-05-29
PCT/JP1988/000525 WO1988009343A1 (en) 1987-05-29 1988-05-28 Fused protein containing lymphotoxin

Publications (2)

Publication Number Publication Date
DE3879395D1 true DE3879395D1 (de) 1993-04-22
DE3879395T2 DE3879395T2 (de) 1993-06-24

Family

ID=15064759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888904653T Expired - Fee Related DE3879395T2 (de) 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin.

Country Status (6)

Country Link
US (1) US5095096A (de)
EP (1) EP0317641B1 (de)
JP (1) JPH082315B1 (de)
AT (1) ATE87007T1 (de)
DE (1) DE3879395T2 (de)
WO (1) WO1988009343A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004692A (en) * 1987-12-15 1991-04-02 Protein Design Labs, Inc. Cloning and expression of phosopholipase C genes
ZA902949B (en) * 1989-05-05 1992-02-26 Res Dev Foundation A novel antibody delivery system for biological response modifiers
SE509359C2 (sv) * 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US6267964B1 (en) 1989-08-01 2001-07-31 Affibody Technology Sweden Ab Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
US5314995A (en) * 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
AU651152B2 (en) * 1990-08-29 1994-07-14 Genetics Institute, Llc Multidomain hematopoiesis stimulators
JPH05255393A (ja) * 1990-09-21 1993-10-05 Ishihara Sangyo Kaisha Ltd ポリペプチド
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US6500646B1 (en) * 1996-12-27 2002-12-31 Mochida Pharmaceutical Co., Ltd. Cell membrane-directed drugs
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
DK1414471T3 (da) 2001-07-17 2012-07-16 Res Dev Foundation Terapeutiske midler omfattende pro-apoptotiske proteiner
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
EP2977055A1 (de) 2010-02-16 2016-01-27 Novo Nordisk A/S Faktor-viii-fusionsproteine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
SE462046C (sv) * 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
NZ212312A (en) * 1984-06-07 1988-09-29 John Richard Murphy Hybrid protein comprising fragments of diphtheria toxin and part of cell-specific ligand; and fused gene therefor
EP0196864A3 (de) * 1985-03-25 1988-03-23 Cetus Corporation Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering

Also Published As

Publication number Publication date
WO1988009343A1 (en) 1988-12-01
EP0317641A1 (de) 1989-05-31
EP0317641A4 (en) 1991-07-24
JPH082315B1 (de) 1996-01-17
ATE87007T1 (de) 1993-04-15
EP0317641B1 (de) 1993-03-17
US5095096A (en) 1992-03-10
DE3879395T2 (de) 1993-06-24

Similar Documents

Publication Publication Date Title
DE3879395D1 (de) Fusionsprotein, enthaltend lymphotoxin.
ES2073081T3 (es) Proteinas de fusion a base de interleucina-2 e hirudina.
ATE140731T1 (de) Plasmidvektor mit pectatlyase-signalsequenz
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ES8605040A1 (es) Procedimiento para preparar un polipeptido con actividad de hirudina
FI943563A0 (fi) Uusia biologisesti aktiivisia polypeptidejä, niiden valmistus ja niitä sisältävä farmaseuttinen koostumus
DE69534381D1 (de) Hämatopoietisches fusionsprotein multivariantes il-3 enthaltend
FI864016A (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
NO863806L (no) Arab promotorer og fremgangsmaate for fremstilling av polypeptider inkludert cecropiner, ved mikrobiologiske teknikker.
ES2072893T3 (es) Endoproteasa kex2 y procedimiento para su produccion.
SE8101005L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfaran...
NZ222856A (en) Equine interferon gamma (eq ifn alpha), dna sequences for its recombinant production and monoclonal antibodies thereto
KR900701819A (ko) 박테리아에서 폴리펩티드 번역 후 수식을 유도하는 선도 서열 및 그의 유전자
DK192189A (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
DE69030937D1 (de) Mutanten von Interleukin-3
ATE170556T1 (de) Dna-sequenzen, vektoren und fusionspolypeptide zur erhöhung der sekretion gewünschter polypeptide von filamentösen fungi
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
SE8101004L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfarande
ES2000859A6 (es) Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion
AU5695086A (en) A dna sequence
ES2005757A6 (es) Un metodo para producir proteinas de fusion por medios recombinantes.
NO883611L (no) Ekspresjonsplasmider som inneholder deo-promotere, og bakterielle verter som inneholder disse plasmidene.
JPS6460388A (en) Gene coding linked material of protein a-like substance fc bond region, recombinant plasmid containing said gene and transformant produced by using said recombinant plasmid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee